Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
McKesson
Dow
Chinese Patent Office
Merck
Express Scripts
Moodys
Cantor Fitzgerald
Cerilliant

Generated: September 18, 2018

DrugPatentWatch Database Preview

Baxter Hlthcare Company Profile

« Back to Dashboard

What is the competitive landscape for BAXTER HLTHCARE, and when can generic versions of BAXTER HLTHCARE drugs launch?

BAXTER HLTHCARE has one hundred and ninety-four approved drugs.

There are five US patents protecting BAXTER HLTHCARE drugs. There are two tentative approvals on BAXTER HLTHCARE drugs.

Summary for Baxter Hlthcare
US Patents:5
Tradenames:304
Ingredients:111
NDAs:194

Drugs and US Patents for Baxter Hlthcare

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare CEFTAZIDIME SODIUM IN PLASTIC CONTAINER ceftazidime sodium INJECTABLE;INJECTION 063221-001 Apr 29, 1993 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare Corp PRISMASOL BGK 2/3.5 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703-003 Oct 25, 2006 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 020047-002 Jul 2, 1991 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare Corp GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 078197-001 Dec 31, 2007 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare TRAVASOL 3.5% W/ ELECTROLYTES amino acids; magnesium chloride; potassium phosphate, dibasic; sodium acetate; sodium chloride INJECTABLE;INJECTION 017493-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare ANCEF IN PLASTIC CONTAINER cefazolin sodium INJECTABLE;INJECTION 063002-002 Mar 28, 1991 RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Baxter Hlthcare

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare IFEX ifosfamide INJECTABLE;INJECTION 019763-001 Dec 30, 1988 4,882,452 ➤ Try a Free Trial
Baxter Hlthcare EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321-001 Dec 20, 2002 4,886,789 ➤ Try a Free Trial
Baxter Hlthcare BREVIBLOC IN PLASTIC CONTAINER esmolol hydrochloride INJECTABLE;INJECTION 019386-004 Feb 16, 2001 4,593,119*PED ➤ Try a Free Trial
Baxter Hlthcare FORANE isoflurane LIQUID;INHALATION 017624-001 Approved Prior to Jan 1, 1982 3,535,388 ➤ Try a Free Trial
Baxter Hlthcare NEXTERONE amiodarone hydrochloride INJECTABLE;INJECTION 022325-001 Dec 24, 2008 5,376,645 ➤ Try a Free Trial
Baxter Hlthcare CYTOXAN (LYOPHILIZED) cyclophosphamide INJECTABLE;INJECTION 012142-008 Jan 4, 1984 4,537,883 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for BAXTER HLTHCARE drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 10 mg/mL, 250 mL infusion bags and 20 mg/mL, 100 mL infusion bags ➤ Subscribe 2014-01-31
➤ Subscribe Inhalation 99.90% ➤ Subscribe 2008-09-11

Non-Orange Book US Patents for Baxter Hlthcare

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,410,077 Sulfoalkyl ether cyclodextrin compositions ➤ Try a Free Trial
9,750,822 Sulfoalkyl ether cyclodextrin compositions ➤ Try a Free Trial
9,200,088 Sulfoalkyl ether cyclodextrin compositions ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Baxter Hlthcare Drugs

Supplementary Protection Certificates for Baxter Hlthcare Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0002 France ➤ Try a Free Trial PRODUCT NAME: MANNITOL; NAT. REGISTRATION NO/DATE: NL 34557 20080819; FIRST REGISTRATION: SE - 22708 20061020
0753 Netherlands ➤ Try a Free Trial PRODUCT NAME: TRASTUZUMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/00/145/002 20130826
C0021 France ➤ Try a Free Trial PRODUCT NAME: PEGAPTANIB SODIUM; REGISTRATION NO/DATE: EU/1/05/325/001 20060131
C/GB97/078 United Kingdom ➤ Try a Free Trial PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522
C0025 Belgium ➤ Try a Free Trial PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215
0612 Netherlands ➤ Try a Free Trial PRODUCT NAME: 4-AMINOPYRIDINE, DAN WEL EEN DERIVAAT DAARVAN, IN HET BIJZONDER EEN ZOUT, SOLVAAT OF PRODRUG; REGISTRATION NO/DATE: EU/1/11/699/001-002 20110720
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
UBS
Harvard Business School
Dow
Julphar
McKesson
Johnson and Johnson
Chinese Patent Office
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.